Titan Pharmaceuticals Inc.

TTNP | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.34

$0.00 (0.00%)

Nov 2, 2026, 3:14 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $3.11M

Enterprise Value $2.78M

Beta 1.38

Average Volume 98.58K

Shares Outstanding (Diluted) 1K

Shares Change YoY -99.89%

Institutional Ownership N/A

Exchange NASDAQ

ISIN KYG1156E1026

Price Performance

Price Change 1M N/A

Price Change 3M N/A

Price Change 6M N/A

Price Change YTD N/A

Price Change 1Y -49.2%

Price Change 3Y -74.6%

Price Change 5Y -93.4%

1M CAGR (ann.) -9.6%

1Y CAGR (ann.) -15.9%

5Y CAGR (ann.) -47.9%

All-Time CAGR -35.9%

Valuation

PE Ratio -0.01

Forward PE 0.13

PEG Ratio 0.00

Forward PEG 0.00

PS Ratio N/A

Forward PS N/A

PB Ratio 2.00

P/FCF Ratio -0.91

P/Adj. FCF Ratio -0.91

P/OCF Ratio -0.00

EV/Sales N/A

EV/EBIT -1.14

EV/EBITDA -1.14

EV/FCF -0.82

Earnings Yield -18454.7%

FCF Yield -109.7%

Adj. FCF Yield -109.7%

Financial Health

Net Cash $328K

Total Debt $0

Cash & Short-Term Investments $328K

Total Assets $4.21M

Current Ratio 1.40

Quick Ratio 1.40

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage 0.00

Altman Z-Score -133.76

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) N/A

Returns

Return on Assets -45.7%

Return on Equity -91.1%

Return on Invested Capital -121.0%

Return on Capital Employed -121.0%

Return on Tangible Assets -45.7%

Historical Growth (CAGR)

Revenue CAGR 3Y -142.3%

Revenue CAGR 5Y -81.2%

Revenue CAGR 10Y -34.1%

EPS CAGR 3Y -143.3%

EPS CAGR 5Y -92.7%

EPS CAGR 10Y -29.0%

FCF CAGR 3Y 38.4%

FCF CAGR 5Y 21.8%

FCF CAGR 10Y 1.6%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date Jan 1, 2026

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Cash Flow

Operating Cash Flow $-3.41M

Free Cash Flow $-3.41M

Adj. Free Cash Flow $-3.41M

FCF Per Share -$2,547.00

OCF Per Share -$2,542.00

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $0

Operating Income $-2.42M

EBITDA $-2.44M

Net Income $-2.49M

EPS (Diluted) -$431.84

Revenue / Employee N/A

Profit / Employee $-621.25K

Employees 4